| INTRODUCTION
The incidence of human papillomavirus-positive (HPV + ) oropharyngeal squamous cell carcinoma (OPSCC) has risen dramatically in recent decades. This is in contrast to HPV-negative (HPV − )
OPSCC, which continues to decline. 1, 2 It has been predicted that by 2020, the annual incidence of HPV + OPSCC will overtake the number of cervical cancers and will represent the majority of head and neck cancers by 2030. 1 HPV + OPSCC has been shown to have a more favourable outcome due to an increased sensitivity to radiotherapy and lower risk of recurrence at the primary site when compared to HPV − OPSCC. 3 However, some patients with HPV + OPSCC have poor outcomes due to formation of distant metastases, which typically manifest later than in HPV − patients, can occur at unusual sites and may display a disseminating or explosive phenotype. 4 Extracellular vesicles (EVs) are nanoscale, membrane enclosed vesicles released by cells to facilitate cell-to-cell communication. 5 EVs contain molecular cargo such as nucleic acids and protein. 6 They are present in all biological fluids 7 , have attracted much attention as a source of biomarkers for disease diagnosis and also as novel therapeutic targets, as their contents appear to be altered in disease. 8 There is evidence that HPV alters the expression of host cell microRNAs [9] [10] [11] and the cargo of EVs released by cervical cancer cells. 12, 13 However, despite the common viral aetiology, there are no similar studies in OPSCC. To address this gap in the literature, we characterised the small EVs released by HPV + and HPV − OPSCC cell lines and performed small RNA sequencing on EV cargo to elucidate the miRNA signature associated with these different tumours.
| ME TH ODS

| Cell culture
During this study, four oropharyngeal carcinoma cell lines were used, which were received under Material Transfer Agreement from Prof.
S. Gollin, University of Pittsburgh School of Public Health, Pittsburgh, PA: SCC2 (hypopharynx), SCC90 (base of tongue), SCC72
(tonsil) and SCC89 (tonsil). Two were HPV16 positive (SCC2 and SCC90), and two were HPV negative (SCC72 and SCC89 Sigma-Aldrich, Dorset, UK). Cells were maintained at 37°C, 5% CO 2 in a humidified environment.
| Conditioned medium and EV isolation
Cells were seeded in complete growth medium and allowed to adhere overnight. Monolayers were washed with PBS and the medium exchanged for DMEM supplemented with 5% (v/v) EV-depleted FBS (centrifuged at 100 000× g for 18 hours and filtered through a 0.2 μm syringe filter) and incubated for 24-72 hours. Conditioned medium was centrifuged at 300× g for 10 minutes, 2000× g for 10 minutes, 10 000× g for 30 minutes. The supernatant was concentrated to 0.5 mL using a Vivaspin-20 (100 MWCO) device (GE Healthcare, Buckinghamshire, UK). EVs were separated from soluble factors by size exclusion chromatography using Sepharose CL-2B
(GE Healthcare, Uppsala, Sweden) stacked in disposable Econo-Pac columns (Biorad, Watford, UK) and eluted in PBS. Where required, EVs were pelleted by ultracentrifugation at 100 000× g for 1 hour.
| Tunable resistive pulse sensing (TRPS)
Extracellular vesicles were analysed by TRPS using a qNano instrument (iZON, Oxford, UK). An NP100 nanopore was selected to measure small EVs. Typical settings were 45 mm stretch, 0.5 V, 10 mbar pressure, but small alterations were made as required to maintain a current of~125 nA. aligned to the whole genome to rescue miRBase unaligned reads.
| Western blotting
| Quantitative real-time PCR
Cellular and EV RNA was reverse transcribed using the small RNA reverse transcription kit with the appropriate RT primer
F I G U R E 1 Analysis of conditioned medium. Cells were allowed to condition EV-depleted medium for 24 h, which was then clarified by differential centrifugation. TRPS analysis was used to determine particle modal diameter (A), concentration (B) and size profile (C). Data represent the average of three independent experiments with error bars indicating SEM. Two-tailed unpaired t test was performed (*P < 0.05, **P < 0.01, ****P < 0.0001)
(A) (B) (C)
F I G U R E 2 Characterisation of isolated EVs. Small EVs were purified by differential centrifugation and SEC. Modal diameters were measured by TRPS (A). EV lysates were examined by western blot using antibodies specific for GM130, CD63, TSG101 and CD9 (B). Size profiles were determined by TRPS (C). Numerical data are the average of 5 independent experiments with error bars indicating SEM. Western blot images are representative of three independent experiments F I G U R E 3 Characterisation of EV RNA cargo. RNA was extracted from EVs and size profile examined by Bioanalyzer (A-D). Small RNA sequencing identified a variety of RNA species (E), including miRNA of different abundance (F). EV miRNA cargo was correlated with HPV status of the producing cell (G) (Applied biosystems, Foster City, CA, USA). QPCR reactions consisted of Taqman mastermix, the appropriate primer/probe sets (Applied biosystems) and cDNA from specific miRNA RT. QPCR was performed using a Rotor Gene Q thermal cycler (Qiagen, Hilden, Germany). Data were normalised to hsa-let-7a-5p (a miRNA expressed at constant levels according to our data) and expressed relative to the sample with lowest abundance/expression using the ΔΔCt method.
| Processing of small RNA sequencing data
Raw sequence reads were aligned to miRBase using the smallRNA_- pathway enrichments were then performed on raw count data from the two groups using DESeq2 14 with a cut-off for log2 Fold Change (log2 FC) of at least 1.5 and a P value < 0.05.
| Pathway analysis
Experimentally validated miRNA targets were determined using miRTarBase v.8 15 for HPV − / + EV enriched sets. Transcripts targeted by multiple miRNA were analysed for pathway enrichment using DAVID 16, 17 to identify head and neck cancer-associated pathways. Stringency criteria were applied using Benjamini-Hochberg correction <0.05.
| RESULTS
| HPV-negative OPSCC cell lines produce more EVs
Prior to purification of OPSCC-derived EVs, we sought to characterise the size profile of small EVs present in conditioned medium.
TRPS using a qNano instrument revealed numerous small particles, most likely EVs, between 50 and 150 nm in diameter (Figure 1 ). 
| Isolation of small EVs from conditioned medium
Small EVs were isolated from the conditioned medium of OPSCC cell lines by a combined differential centrifugation and size exclusion chromatography (SEC) approach. EV-rich fractions were combined and EVs were pelleted by ultracentrifugation (100 000× g for 1 hour).
Pelleted EVs were resuspended in 50 μL PBS or protein lysis buffer for subsequent TRPS or western blot analysis, respectively. TRPS confirmed the isolation of small EVs with similar modal diameters to the particles detected in conditioned medium (compare Figures 1A   and 2A) . Analysis of the EV size profiles showed that all samples contained particles between 50 and 150 nm in diameter with a skewed normal distribution ( Figure 2C) . Interestingly, the size profile of purified SCC89 EVs was similar to the other samples, suggesting that a proportion of the EVs larger than 80 nm (present in conditioned medium samples) were eliminated during the purification procedure ( Figure 2C ). Western blot analysis revealed that EV lysates were positive for the EV markers CD63, CD9 or TSG101, whereas the Golgi marker GM130 was only detected in cell lysates ( Figure 2B ).
| EVs isolated from OPSCC cell lines contain a variety of small RNA molecules
RNA was extracted from EV pellets and subjected to Bioanalyzer analysis, which showed that samples were enriched with small RNA species <200 nt in length ( Figure 3A-D) . Small RNA sequencing produced 8-13 million reads per sample, with 89-94% mapped to mirBase and the human genome. Of these mapped reads, 2-15% aligned to miRNA sequences. Other RNA species that were identified included mRNA, rRNA, tRNA, snoRNA, snRNA and lincRNA (Figure 3E) . Raw counts were converted to reads per million (RPM). For each sample, 343-443 unique miRNA were identified. 63-82 miRNA had high abundance (>1000 RPM), 73-92 miRNA had intermediate abundance (100-1000 RPM) and 117-133 miRNA had low abundance (10-100 RPM; Figure 3F ).
| EV miRNA profile correlates with HPV status
MiRNA data were converted to log2 RPM and unbiased hierarchical clustering analysis revealed that the global EV miRNA signature cor- 
D). RNA was extracted from EVs and subject to quantitative real-time PCR (QPCR) (B, E).
The cellular miRNA expression level was measured by QPCR (C, F). For each repeat, EVs were isolated from conditioned medium taken from three confluent T-175 flasks, per cell line. QPCR data were normalised to hsa-let-7a-5p and expressed relative to the sample with lowest target abundance. Data represent the average of two independent experiments with error bars indicating SEM identify specific miRNA associated with HPV status, fold difference was calculated between HPV + and HPV − groups using DEseq2, with a cut-off of 1.5 log2 fold change and P value of < 0.05. 14 miRNA were identified that were enriched in EVs from HPV + cells, and 19 miRNA were identified that were enriched in EVs from HPV − cells (Table 1 ). In addition, 9 miRNA were very abundant in all EV samples (>5000 RPM), independent of HPV status (Table 1) . We next sought to validate small RNA sequencing data by quantitative real-time PCR (QPCR). miR-29b-3p and miR-20b-5p were chosen as miRNA that were enriched in EVs derived from HPV − or HPV + cells, respectively.
The pattern of enrichment seen in small RNA sequencing data (Figure 4A,D) was also observed by QPCR analysis (Figure 4B ,E). We also examined the cellular expression level of each miRNA, which showed that the EV abundance showed a similar trend to that of cellular expression ( Figure 4C,F) . miR-20b-5p has been described as a core HPV upregulated miRNA because it is consistently upregulated in HPV + OPSCC 20 and cervical cancer tissues. 18 Increased miR-20b-5p expression in cervical cancer is dependent on the viral E6 oncoprotein and has been shown to promote cancer cell invasion. 21 However, expression of the normally silent miR-20b-5p and other miRNA cluster members (miR-106a-5p
and miR-363-3p) caused a decrease in proliferation in oral squamous cell carcinoma cells 22 , highlighting the cancer-specific role of certain miRNAs. We found an enrichment of miR-9-5p and miR-9-3p in HPV + EVs, which is consistent with reports of their overexpression in HPV + OPSCC 20 and HPV + cervical cancer. 23 The most highly enriched miRNA in HPV − EVs was miR-767-5p, which has been shown to be overexpressed in some tumours and to target members of the TET family of tumour suppressors. 24 miR-105-5p was similarly enriched in HPV − EVs and has been reported to promote breast cancer metastasis by EV mediated targeting of endothelial cells. 25 We found that miR-100-5p was enriched in EVs derived from HPV − OPSCC cells. Interestingly, Honegger et al reported that cellular expression and packaging of miR-100-5p into EVs was increased in HeLa cells upon silencing of cellular E6/E7 viral oncogene expression. 13 Cellular expression of miR-100-5p has previously been shown to be downregulated in response to HPV16/18 viral infection in an E6/E7 dependent manner.
11
The miRNA cargo of EVs represents a source of circulating biomarkers that may be useful in diagnosing and monitoring cancer.
Our data show that EVs contain overlapping miRNA profiles, but that certain miRNAs may be cancer and subtype specific. Indeed, unbiased hierarchical clustering of EV miRNA cargo grouped samples in this study based on the HPV status of the producing cell. The detection of these EV-encapsulated miRNA signatures in biological fluids might be a suitable method for surveillance of OPSCC patients to detect catastrophic metastatic recurrence.
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